“drugs” Archives

in
Entry Author Date Location
Lacking Details, Roche Touts Drug Combo’s Success in Lung Cancer 11/20/17 San Francisco
Ed Kaye on Sarepta’s Duchenne Quest, Rising to CEO & His New Startup 11/20/17 Boston
Xconomy Peers into Biotech Future with Vividion’s Diego Miralles 11/16/17 San Diego
Acorda Takes Another Hit, Reports Patient Deaths in Parkinson’s Study 11/15/17 New York
Inozyme Gets $49M From Sanofi, Novo to Tackle Rare Infant Disease 11/15/17 Boston
In a Precision Step, Bayer Writes Loxo $400M Check for Two Cancer Drugs 11/14/17 New York
Bio Roundup: Barron Joins GSK, Sage Bounces Back, Valeant Dumps Addyi 11/10/17 National
Sage Bounces Back, Eyes FDA Filing for Postpartum Drug 11/09/17 Boston
Klotho Therapeutics Raises $10M to Test Drug in Kidney Disease 11/03/17 San Diego
John Mendlein Passes Torch to New CEO at San Diego’s aTyr Pharma 11/01/17 San Diego
Terminated Blood Cancer Drug Springs Back to Life at SD Biotech 10/26/17 San Diego
Xconomy Q&A: An Update with Arcturus Therapeutics CEO Joseph Payne 10/23/17 San Diego
Phrixus to Launch Clinical Trials for Duchenne Drug in Early 2018 10/16/17 Detroit Ann Arbor
JLABS Takes Stock of Its Experiment in Life Sciences Innovation 10/13/17 San Diego
VC Funding Surges in Fewer Deals in Third Quarter, and Top 10 Deals 10/10/17 National
Strata Oncology, UCSF Partner to Offer $25M in Free Tumor Sequencing 10/05/17 Detroit Ann Arbor
No Effect: Axovant Drug Is Latest Casualty in Alzheimer’s Battle 09/26/17 National
Poizner Updates Plan for Alliance on Southern California Innovation 09/25/17 San Diego
Bio Roundup: RNAi’s Big Day, CAR-T For Kids, Drugs From Fungi & More 09/22/17 National
Alnylam Data Puts a Nobel Discovery One Step Closer to Approved Drug 09/20/17 Boston
Amicus’s Scioderm Deal Flops as Skin Drug Fails in Phase 3 09/13/17 New York
All Eyes on Depression Trials as Sage Neuro Drug Flunks Epilepsy Test 09/12/17 Boston
Regeneron Touts Success in Big Asthma Drug Study, Plans FDA Filing 09/11/17 New York
On Eve of Big Data Reveal, Patient Death Stalls Alnylam Hemophilia Drug 09/07/17 Boston
Seeking to Cash in For Investors Again, Rhythm Pharma Files For IPO 09/06/17 Boston
As Key Data Loom, Nobel Winner Mello Reflects on RNAi “Sci-Fi” Story 09/06/17 Boston
Presage Bio Licenses Anti-Cancer Drug to San Diego’s MEI Pharma 09/05/17 San Diego
Otonomy Scraps Hearing Loss Drug After Phase 3 Flop, Shares Routed 08/30/17 San Diego
FDA Refuses to Review Acorda Parkinson’s Drug, Shares Tumble 08/29/17 New York
Gilead Makes Long-Awaited Splash With $12B Bet on Kite, Cell Therapy 08/28/17 San Francisco
Page 1 of 96 next page »